0.58
price up icon1.72%   0.0098
after-market Dopo l'orario di chiusura: .58
loading
Precedente Chiudi:
$0.5702
Aprire:
$0.5702
Volume 24 ore:
12,273
Relative Volume:
0.14
Capitalizzazione di mercato:
$3.49M
Reddito:
$14.64M
Utile/perdita netta:
$-13.74M
Rapporto P/E:
-0.0798
EPS:
-7.27
Flusso di cassa netto:
$-5.04M
1 W Prestazione:
-3.33%
1M Prestazione:
-4.92%
6M Prestazione:
+5.26%
1 anno Prestazione:
-78.48%
Intervallo 1D:
Value
$0.5702
$0.5872
Intervallo di 1 settimana:
Value
$0.5601
$0.61
Portata 52W:
Value
$0.3611
$9.079

Novabay Pharmaceuticals Inc Stock (NBY) Company Profile

Name
Nome
Novabay Pharmaceuticals Inc
Name
Telefono
510-899-8800
Name
Indirizzo
2000 Powell Street, Suite 1150, Emeryville, CA
Name
Dipendente
86
Name
Cinguettio
@NovaBayPharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
NBY's Discussions on Twitter

Confronta NBY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NBY
Novabay Pharmaceuticals Inc
0.58 3.49M 14.64M -13.74M -5.04M -7.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2019-09-18 Iniziato Ladenburg Thalmann Buy
2018-07-06 Reiterato H.C. Wainwright Buy
2017-11-15 Reiterato Laidlaw Buy
2017-06-05 Iniziato ROTH Capital Buy
2017-03-27 Iniziato Laidlaw Buy
2017-02-06 Iniziato Rodman & Renshaw Buy
2016-03-07 Downgrade Maxim Group Buy → Hold
2015-12-14 Reiterato Maxim Group Buy
2015-04-30 Ripresa Maxim Group Buy
2013-03-06 Iniziato Ascendiant Capital Markets Strong Buy
2008-01-03 Iniziato Dawson James Speculative Buy
Mostra tutto

Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie

pulisher
Apr 26, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by Analysts at StockNews.com - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 22, 2025

NovaBay Pharmaceuticals approves liquidation plan By Investing.com - Investing.com Canada

Apr 22, 2025
pulisher
Apr 22, 2025

NovaBay Pharmaceuticals approves liquidation plan - Investing.com

Apr 22, 2025
pulisher
Apr 16, 2025

Poplar Point Capital Partners acquires $39,503 in NovaBay shares - Investing.com Australia

Apr 16, 2025
pulisher
Apr 16, 2025

Poplar Point Capital Partners increases stake in NovaBay Pharmaceuticals By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 15, 2025

Massive Stock Acquisition: Poplar Point Capital Partners Bets Big on NovaBay Pharma! - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

Poplar Point Capital Partners acquires $29,857 in NovaBay shares - Investing.com Australia

Apr 15, 2025
pulisher
Apr 15, 2025

Poplar Point Capital increases stake in NovaBay Pharmaceuticals By Investing.com - Investing.com India

Apr 15, 2025
pulisher
Apr 15, 2025

Poplar Point Capital Partners acquires $39,503 in NovaBay shares By Investing.com - Investing.com India

Apr 15, 2025
pulisher
Apr 15, 2025

Poplar Point Capital Partners acquires $29,857 in NovaBay shares By Investing.com - Investing.com Canada

Apr 15, 2025
pulisher
Apr 15, 2025

Novabay Pharmaceuticals sees $15,966 in recent stock acquisitions - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

Novabay Pharmaceuticals sees $15,966 in recent stock acquisitions By Investing.com - Investing.com UK

Apr 15, 2025
pulisher
Apr 15, 2025

Poplar Point Capital increases stake in NovaBay Pharmaceuticals - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

NovaBay Pharmaceuticals sees $67,700 stock acquisition by Poplar Point Capital - Investing.com India

Apr 15, 2025
pulisher
Apr 02, 2025

NovaBay Pharmaceuticals Inc. (NBY) reports earnings - qz.com

Apr 02, 2025
pulisher
Apr 01, 2025

NovaBay Pharmaceuticals Delays Yearly Report Filing - TipRanks

Apr 01, 2025
pulisher
Mar 28, 2025

CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga

Mar 28, 2025
pulisher
Mar 27, 2025

Revolutionizing Healing: Trends in the Advanced Wound Care Market with NovaBay, Healthy.io - openPR.com

Mar 27, 2025
pulisher
Mar 24, 2025

Blepharitis Treatment Market Future Business Opportunities - openPR.com

Mar 24, 2025
pulisher
Mar 18, 2025

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Significant Decrease in Short Interest - Defense World

Mar 18, 2025
pulisher
Mar 18, 2025

NovaBay Pharmaceuticals (NBY) Projected to Post Quarterly Earnings on Tuesday - Defense World

Mar 18, 2025
pulisher
Mar 12, 2025

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Share Price Passes Above 50-Day Moving Average – Time to Sell? - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

NovaBay reaches settlements over disputed warrants By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 11, 2025

NovaBay reaches settlements over disputed warrants - Investing.com India

Mar 11, 2025
pulisher
Mar 08, 2025

NovaBay Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 07, 2025

Novabay Pharmaceuticals Engages Financial Advisor Should Stockholders Fail To Approve Dissolution Proposal - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire

Mar 07, 2025
pulisher
Mar 06, 2025

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Update - Defense World

Mar 06, 2025
pulisher
Mar 01, 2025

StockNews.com Initiates Coverage on NovaBay Pharmaceuticals (NYSE:NBY) - Defense World

Mar 01, 2025
pulisher
Feb 27, 2025

Investor Network: NovaBay Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

NovaBay's Avenova Highlighted in National Dry Eye Awareness Month - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 21, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Earns Hold Rating from Analysts at StockNews.com - Defense World

Feb 21, 2025
pulisher
Feb 17, 2025

NovaBay extends CEO's contract through 2025 - MSN

Feb 17, 2025
pulisher
Feb 13, 2025

StockNews.com Begins Coverage on NovaBay Pharmaceuticals (NYSE:NBY) - Defense World

Feb 13, 2025
pulisher
Feb 08, 2025

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Crosses Above Fifty Day Moving Average – Time to Sell? - Armenian Reporter

Feb 08, 2025
pulisher
Feb 06, 2025

NovaBay fails to gain shareholder approval for dissolution - MSN

Feb 06, 2025
pulisher
Feb 04, 2025

NovaBay fails to gain shareholder approval for dissolution By Investing.com - Investing.com Canada

Feb 04, 2025
pulisher
Jan 28, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated at StockNews.com - Defense World

Jan 28, 2025
pulisher
Jan 25, 2025

**NovaBay Pharmaceuticals Completes Asset Sale Transaction and Plans for Dissolution**** - Defense World

Jan 25, 2025
pulisher
Jan 24, 2025

NovaBay Pharmaceuticals Completes the Sale of its Avenova Eyecare Business to PRN, Seeks Full Company Dissolution - Vision Monday

Jan 24, 2025
pulisher
Jan 23, 2025

NovaBay Pharma’s Strategic Shift and Liquidation Plans - TipRanks

Jan 23, 2025

Novabay Pharmaceuticals Inc Azioni (NBY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Capitalizzazione:     |  Volume (24 ore):